Family with sequence similarity 84, member B (FAM84B) antisense nucleotide and application thereof
A technology of antisense nucleotides and nucleotide sequences, which is applied in the direction of recombinant DNA technology, DNA/RNA fragments, and the use of vectors to introduce foreign genetic materials, etc., can solve problems such as interference, reduce the degree of malignancy, reduce the number, and improve specific effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Example 1 Construction and identification of pSuper-shRNA-FAM84B expression vector
[0025] (1) siRNA sequence design
[0026] Design the 21nt siRNA target sequence for FAM84B according to the siRNA Target Finder software, design and construct the shRNA forward and reverse oligonucleotide sequences corresponding to the gene silencing expression vector pSUPER, the forward oligonucleotide sequence is SEQ ID No.2 (the antisense oligonucleotide sequence containing oligonucleotide sequence SEQ ID No.1 and its SEQ ID No.1), the reverse oligonucleotide sequence is SEQ ID No.3 (containing oligonucleotide sequence SEQ ID No.3) ID No.1 and its antisense oligonucleotide sequence of SEQ ID No.1).
[0027] The sequence of the control siRNA is SEQ ID No.4. The forward oligonucleotide sequence corresponding to this sequence to construct the gene silencing expression vector pSUPER is SEQ ID No.5, and the reverse oligonucleotide sequence is SEQ ID No.6. for subsequent experiments.
...
Embodiment 2 Embodiment 1
[0046] Inhibition of FAM84B expression by the expression vector constructed in Example 2 Example 1
[0047] The successfully constructed pSuper-shRNA-control and pSuper-shRNA-FAM84B expression vectors were transfected into NCI-H716 cells respectively, and NCI-H716 was stably transfected with pSuper-shRNA-FAM84B cell line, and verified by Real-time RT-PCR Effects of FAM84B silencing.
[0048] Transfection: experimental group: pSuper-shRNA-FAM84B group; control group: pSuper-shRNA-control group.
[0049] The above plasmids were transfected into NCI-H716 cells, and the transfection reagent liposome (PEI) was added, and the operation was performed according to the instructions. After 24 hours of transfection, 2.0 μg / ml of puromycin was added for stable selection, and the culture medium containing the same concentration of puromycin was replaced in 2-3 days. After 7 days, the cells in the blank control group were basically dead, while the cells in the transfection group had scatt...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com